Oculis Holding AG Ordinary shares (OCS) Stock Analysis

Oculis Holding AG Ordinary shares (OCS) is a publicly traded company in the HEALTHCARE sector. It trades at $12.29, carries a market capitalization of $876.23M. This page summarizes the public market data, fundamentals, and frequently asked questions for OCS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Oculis Holding AG Ordinary shares currently has a Bearish sentiment score of -0.23.

About Oculis Holding AG Ordinary shares

Oculis Holding AG is an innovative biopharmaceutical company based in Zug, Switzerland, specializing in the development of groundbreaking topical therapies for a range of ophthalmic diseases affecting both the front and back of the eye. Leveraging advanced formulation technologies, Oculis aims to address significant unmet medical needs in vision care, focusing on enhancing patient outcomes through effective and user-friendly treatment options. With its robust pipeline, the company is position...

GNG Research Analysis

GNG Research scores Oculis Holding AG Ordinary shares (OCS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for OCS.

Frequently Asked Questions

Does OCS pay dividends?

Oculis Holding AG Ordinary shares (OCS) does not currently pay a regular dividend.

What is OCS's market cap?

Oculis Holding AG Ordinary shares (OCS) has a market capitalization of $876.23M with a current stock price of $12.29.